drugset / Trial / NCT01425853

Study on Efficacy and Safety of Chondroitin Sulfate + Glucosamine Hydrochloride Versus Celecoxib in Knee Osteoarthritis

NCT01425853 ↗

Phase 4 Completed 606 enrolled Bioiberica
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether the combination of Chondroitin sulfate (CS) and Glucosamine Hydrochloride (GH) has similar efficacy to Celecoxib (CE) in the treatment of patients with moderate to severe knee osteoarthritis (OA).

Timeline

Start
2011-09
Primary completion
2013-04
Completion
2013-05

Outcome

Met primary endpoint

paper meeting the non-inferiority margin of -40: -1.11 (-22.0 to 19.8; p=0.92). PMID 25589511 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Celecoxib Other / unclassified 200 mg —
Subject Chondroitin sulfate Unknown 400 mg —
Subject Glucosamine Small molecule 500 mg —

Indications